WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Ceribell clears three EEG algorithms under K261712 with no age limit Oura shelves its $2.2B Nasdaq IPO four weeks after filing VCD Medical clears VEnice, a clip that closes varicose veins without heat Sofinnova closes an 82 million euro fund to start six to eight device companies Nyxoah hires former Teleflex CEO Liam Kelly to run the Genio US launch SI-BONE clears Granite Onyx, its first compromised bone implant outside the pelvis Route 92 Medical clears the FreeClimb 46, the smallest catheter in its stroke line Insera clears the CLEAR aspiration system for peripheral clot removal under K253404 Webster Equity takes Lifecore Biomedical private at $6.28 a share plus CVRs Ceribell clears three EEG algorithms under K261712 with no age limit Oura shelves its $2.2B Nasdaq IPO four weeks after filing VCD Medical clears VEnice, a clip that closes varicose veins without heat Sofinnova closes an 82 million euro fund to start six to eight device companies Nyxoah hires former Teleflex CEO Liam Kelly to run the Genio US launch SI-BONE clears Granite Onyx, its first compromised bone implant outside the pelvis Route 92 Medical clears the FreeClimb 46, the smallest catheter in its stroke line Insera clears the CLEAR aspiration system for peripheral clot removal under K253404 Webster Equity takes Lifecore Biomedical private at $6.28 a share plus CVRs

510(k)

VCD Medical clears VEnice, a clip that closes varicose veins without heat

MedDevice Startups Staff · 23 hrs ago · 2 min read · Via VCD Medical (GlobeNewswire)

FDA cleared VCD Medical's VEnice vein closure device on September 29. The indication covers percutaneous and surgical closure of superficial and perforator veins in patients with varicose veins.

VEnice deploys a pre-loaded implantable clip through a 17-gauge needle applicator under ultrasound guidance, compressing the vein shut. The handheld applicator carries an integrated suture cutter. No thermal energy is involved, which places it outside both the ablation and sclerotherapy categories that own the indication today.

A mechanical closure with no generator and no tumescent anesthesia is a different reimbursement and site-of-service argument than radiofrequency or laser, and that is the part US payers will decide. Interim six-month results from the BERG02 study of percutaneous ligation with sclerotherapy are due at The VEINS meeting in October.

VCD Medical is based in Brescia, Italy, and was founded in 2021. It named Denna Babul US general manager in May.

Questions & Answers

What is the VCD Medical VEnice device cleared for?

FDA cleared the VCD Medical VEnice vein closure device on September 29, 2026 for percutaneous and surgical closure of superficial and perforator veins in patients with varicose veins.

How does the VEnice vein closure device work?

VEnice delivers a pre-loaded implantable clip through a 17-gauge needle applicator under ultrasound guidance, compressing and occluding the target vein. The handheld applicator includes an integrated suture cutter, and the method uses no thermal energy.

Where is VCD Medical based?

VCD Medical is based in Brescia, Italy, and was founded in 2021. The VEnice device is its first FDA-cleared product in the United States.

← Back to Newly Cleared